Editor:
We read the informative article published by Dangis et al in the journal about the accuracy of low-dose chest CT in the diagnosis of COVID-19 disease (1). Considering that in many settings chest CT scan is used widely for detection of COVID-19 pneumonia, using a low-dose protocol especially in patients younger than 40 years is important. This interesting study reported accuracy of 90.2% in all patients and 94% in the subset of patients with chest CT performed 48 hours after the symptom’s onset. The sensitivity and specificity values were respectively 86.7% and 93.6%, while in a recent meta-analysis including 63 studies, Kim et al (2) reported combined sensitivity and specificity of chest CT for the diagnosis of COVID -19, considering PCR test as the reference standard, as 94% and 37%, respectively. Pooled prevalence of COVID-19 mainly from reports in China is about 39%, which is near to what Dangis et al (1) report with described pretest probability of 43%. Additionally, we have conducted a study in Tehran, Iran, utilizing low-dose chest CT on 163 patients and observed a sensitivity value of 96.6% (95% CI: 90%, 99%), and specificity value of 36.5% (95% CI: 26%, 49%) (unpublished results), more compatible with the numbers in the mentioned meta-analysis. Although Dangis et al (1) stated that a potential reason for their high specificity was the repeated RT-PCR test after 24 hours in cases with initial negative RT-PCR result, the specificity of standard-dose CT scan in four previous studies with repeated RT-PCR have ranged between 25% and 56% (3-6). It seems that other explanations for the observed high specificity of low-dose chest CT should be explored. Additionally, the specificity of low-dose CT scan for subset of patients with initial negative RT-PCR results are not reported separately in their study.
In conclusion, this remarkable study by Dangis et al (1) demonstrates excellent accuracy of low-dose chest CT in the diagnosis of COVID-19 pneumonia, with exceptional high specificity compared to previous standard-dose studies, which remains to be further validated.
References
- 1.Dangis A, Gieraerts C, Bruecker YD, Janssen L, Valgaeren H, Obbels D, Gillis M, Ranst MV, Frans J, Demeyere A, Symons R. Accuracy and reproducibility of low-dose submillisievert chest CT for the diagnosis of COVID-19. Radiol: Cardiothoracic Imaging. 2020 Apr 21;2(2):e200196. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Kim H, Hong H, Yoon SH. Diagnostic Performance of CT and Reverse Transcriptase-Polymerase Chain Reaction for Coronavirus Disease 2019: A Meta-Analysis. Radiology. 2020 Apr 17:201343. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, Tao Q, Sun Z, Xia L. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology. 2020 Feb 26:200642. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Zhu W, Xie K, Lu H, Xu L, Zhou S, Fang S. Initial clinical features of suspected Coronavirus Disease 2019 in two emergency departments outside of Hubei, China. Journal of Medical Virology. 2020 Mar 13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Cheng Z, Lu Y, Cao Q, Qin L, Pan Z, Yan F, Yang W. Clinical features and chest CT manifestations of coronavirus disease 2019 (COVID-19) in a single-center study in Shanghai, China. American Journal of Roentgenology. 2020 Mar 14:1-6. [DOI] [PubMed] [Google Scholar]
- 6.Caruso D, Zerunian M, Polici M, Pucciarelli F, Polidori T, Rucci C, Guido G, Bracci B, de Dominicis C, Laghi A. Chest CT features of COVID-19 in Rome, Italy. Radiology. 2020 Apr 3:201237. [DOI] [PMC free article] [PubMed] [Google Scholar]